Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative acetaminophen suppository for emergence agitation in pediatric elective surgery
IRCT20170515033986N8Phase 3Recruiting
- Sponsor
- Urmia University of Medical Sciences
- Start
- Sep 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of acetaminophen in Emergence agitation (EA) (2 arms), sponsored by Urmia University of Medical Sciences. Primary endpoint: Recovery agitation. Started Sep 2026; status: recruiting.
02
Drugs
acetaminophen
03
Conditions
Emergence agitation (EA)
Beyond the preview
Go deeper on IRCT20170515033986N8.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20170515033986N8.